AU2526497A - Post-labeling stabilization of radiolabeled proteins and peptides - Google Patents
Post-labeling stabilization of radiolabeled proteins and peptidesInfo
- Publication number
- AU2526497A AU2526497A AU25264/97A AU2526497A AU2526497A AU 2526497 A AU2526497 A AU 2526497A AU 25264/97 A AU25264/97 A AU 25264/97A AU 2526497 A AU2526497 A AU 2526497A AU 2526497 A AU2526497 A AU 2526497A
- Authority
- AU
- Australia
- Prior art keywords
- labeling
- peptides
- stabilization
- post
- radiolabeled proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1102796P | 1996-02-02 | 1996-02-02 | |
US011027 | 1996-02-02 | ||
PCT/US1997/001695 WO1997028181A2 (en) | 1996-02-02 | 1997-02-03 | Post-labeling stabilization of radiolabeled proteins and peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2526497A true AU2526497A (en) | 1997-08-22 |
Family
ID=21748542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU25264/97A Withdrawn AU2526497A (en) | 1996-02-02 | 1997-02-03 | Post-labeling stabilization of radiolabeled proteins and peptides |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2526497A (en) |
CA (1) | CA2279349C (en) |
WO (1) | WO1997028181A2 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7919109B2 (en) | 1999-02-08 | 2011-04-05 | Intarcia Therapeutics, Inc. | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
US7258869B1 (en) | 1999-02-08 | 2007-08-21 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle |
AU2002218751A1 (en) * | 2000-07-06 | 2002-01-21 | Bristol-Myers Squibb Pharma Company | Stable radiopharmaceutical compositions |
IL157359A0 (en) * | 2001-02-26 | 2004-02-19 | Bristol Myers Squibb Pharma Co | A radiopharmaceutical composition containing an ascorbic acid analog |
US7238338B1 (en) | 2001-06-22 | 2007-07-03 | Triumf | System and method for the large scale labeling of compounds with radiohalogens |
US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
DK2020990T3 (en) | 2006-05-30 | 2010-12-13 | Intarcia Therapeutics Inc | An internal channel flow modulator for a two-part osmotic feeding system |
CA2670821C (en) | 2006-08-09 | 2012-05-15 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies |
MX2009011123A (en) | 2007-04-23 | 2009-11-02 | Intarcia Therapeutics Inc | Suspension formulations of insulinotropic peptides and uses thereof. |
WO2009102467A2 (en) | 2008-02-13 | 2009-08-20 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
US20100196272A1 (en) * | 2009-01-30 | 2010-08-05 | Neoprobe Corporation | Compositions for radiolabeling diethylenetriaminepentaacetic acid (dtpa)-dextran |
KR101823699B1 (en) | 2009-09-28 | 2018-01-30 | 인타르시아 세라퓨틱스 인코포레이티드 | Rapid establishment and/or termination of substantial steady-state drug delivery |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
AU2016270984B2 (en) | 2015-06-03 | 2021-02-25 | Intarcia Therapeutics, Inc. | Implant placement and removal systems |
CA3016901C (en) * | 2016-03-07 | 2023-06-13 | Actinium Pharmaceuticals, Inc. | Stabilized radiolabeled anti-cd45 immunoglobulin compositions |
AU2017268161B2 (en) | 2016-05-16 | 2020-03-12 | Intarcia Therapeutics, Inc. | Glucagon-receptor selective polypeptides and methods of use thereof |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
IL307966A (en) | 2017-01-03 | 2023-12-01 | Intarcia Therapeutics Inc | Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4401646A (en) * | 1981-05-08 | 1983-08-30 | University Patents Inc. | Method and apparatus for purifying materials radiolabeled with technetium-99m |
US4988496A (en) * | 1988-05-31 | 1991-01-29 | Neorx Corporation | Metal radionuclide chelating compounds for improved chelation kinetics |
US5011676A (en) * | 1990-03-27 | 1991-04-30 | Thomas Jefferson University | Method to directly radiolabel antibodies for diagnostic imaging and therapy |
DE69231469T2 (en) * | 1991-08-29 | 2001-01-25 | Mallinckrodt Medical, Inc. | USE OF GENTISIC ACID OR GENTISYL ALCOHOL TO STABILIZE RADIO-LABELED PEPTIDES AND PROTEINS |
US5225180A (en) * | 1991-09-10 | 1993-07-06 | Diatech, Inc. | Technetium-99m labeled somatostatin-derived peptides for imaging |
-
1997
- 1997-02-03 WO PCT/US1997/001695 patent/WO1997028181A2/en active Application Filing
- 1997-02-03 CA CA002279349A patent/CA2279349C/en not_active Expired - Fee Related
- 1997-02-03 AU AU25264/97A patent/AU2526497A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO1997028181A2 (en) | 1997-08-07 |
CA2279349C (en) | 2007-09-25 |
CA2279349A1 (en) | 1997-08-07 |
WO1997028181A3 (en) | 1997-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2526497A (en) | Post-labeling stabilization of radiolabeled proteins and peptides | |
EP0785276A4 (en) | Modification of peptide and protein | |
HK1003503A1 (en) | Aerosol formulations of peptides and proteins | |
HUP0000810A3 (en) | Proteins with enhanced levels of essential amino acids | |
EP0880356A4 (en) | Antimicrobial peptides and methods of use | |
EP1071706A4 (en) | Rapidly degrading gfp-fusion proteins and methods of use | |
AU4727296A (en) | Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation | |
AU2548097A (en) | Formulations of ob protein | |
AU2572797A (en) | Adam proteins and uses thereof | |
AU1159897A (en) | Analogs of peptide yy and uses thereof | |
AU2091799A (en) | Uses of alpha-conotoxin peptides | |
AU6585498A (en) | Novel uncoupling protein and methods of use | |
AU4977796A (en) | Modified lysine or arginine containing proteins and peptides | |
AU4013495A (en) | Chemokine-like proteins and methods of use | |
AU4074997A (en) | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides | |
AU4236097A (en) | Mhc peptides and methods of use | |
AU7238098A (en) | Peptides having cyclic structures and exerting p53 protein activty-restoring effect on p53 protein mutants | |
AU3451397A (en) | Modified protein g and fragments thereof | |
PL321239A1 (en) | Mutations of proteins | |
EP1029034A4 (en) | Signal peptide containing proteins and uses therefor | |
HUP9801330A3 (en) | Novel pka-binding proteins and uses thereof | |
AU3964499A (en) | Agouti-related protein analogs and methods of use | |
AU6301698A (en) | Anti-hiv peptides and proteins | |
AU4927000A (en) | Labelling of peptides and proteins | |
IL128746A0 (en) | Ptx-sensitive g proteins their preparation and use |